Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 09, 2026 08:45 ET | Source: Amplia Therapeutics Limited

Amplia Announces Publication of New FAK Inhibitor Patent Application

HIGHLIGHTS New patent application published covering chemically novel FAK inhibitors discovered by AmpliaApplication expands Amplia’s intellectual property portfolio supporting its FAK inhibitor...
July 07, 2026 08:45 ET | Source: Amplia Therapeutics Limited

Amplia Announces Appointment of Brett Carter to Board

Melbourne, Australia, July 07, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX, OTCQB:INNMF), (“Amplia” or the “Company”), is pleased to announce the appointment of Mr Brett Carter to...
July 06, 2026 08:45 ET | Source: Amplia Therapeutics Limited

Amplia Announces Changes to Board’s Leadership Roles

Melbourne, Australia, July 06, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX, OTCQB:INNMF), (“Amplia” or the “Company”), announces Board changes further to a Board renewal and...
June 22, 2026 08:45 ET | Source: Amplia Therapeutics Limited

Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer

Melbourne, Australia, June 22, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX | OTCQB:INNMF), (“Amplia” or the “Company”) provides a letter to shareholders from CEO and Managing...